TRIPS PLUS MEASURES UNDER RCEP NEGOTIATIONS THREATEN PUBLIC ACCESS TO MEDICINES (original) (raw)

Journal of Intellectual Property Rights (JIPR) : [776] ISSN: 0975-1076 (Online); 0971-7544 (Print) JIPR Vol.22(6) [November 2017] Page(s): 295-302, 2017

View PDFchevron_right

Intellectual Property Rights In Bilateral Investment Treaties and Access to Medicines: the Case of Latin America

Rosa Castro

The Journal of World Intellectual Property, 2006

View PDFchevron_right

The T(i)PP(ing) Point for Pharma: Why having TRIPS+ patenting standards in the TPP is bad news for Developing Countries

Akhil Raina

2017

View PDFchevron_right

Trade Rules and Intellectual Property Protection for Pharmaceuticals

Valbona Muzaka

View PDFchevron_right

Patents and the Trans-Pacific Partnership: How TPP-style intellectual property standards may exacerbate the access to medicines problem in the East African Community

Olugbenga Ajani Olatunji, Bukola Faturoti

The International Trade Journal

View PDFchevron_right

Effects Of The Trade Related Aspects of Intellectual Property (TRIPS) On Access to Pharmaceuticals in Developing Countries

Birute Aleknaite

View PDFchevron_right

Access to medicines and incentives for innovation: The balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products

Raquel Artecona

2016

View PDFchevron_right

The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines under the Amended TRIPS Provisions†

Jerome Reichman

Journal of International Economic Law - J INT ECON LAW, 2007

View PDFchevron_right

The Inadequate Global Policy Response to Trade-Related Intellectual Property Rights: Impact on Access to Medicines in Low- and Middle-Income Countries

Lisa Forman

Maryland Journal of International Law, 2016

View PDFchevron_right

Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016

Brigit Toebes

Bulletin of the World Health Organization, 2018

View PDFchevron_right

Reframing the issue: The WTO coalition on intellectual property and public health, 2001

Susan Sell

… , ed. Negotiating Trade: Developing Countries in …, 2006

View PDFchevron_right

Policy & practice Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016

Brigit Toebes

View PDFchevron_right

Doha Declaration and access to drugs and medicines

Anjali Mohandas

View PDFchevron_right

Reconciling the global public health interest with intellectual property protection through the waiver of certain provisions of the WTO TRIPS Agreement

Patrick Osode

Yuridika, 2022

View PDFchevron_right

Developing Countries and Intellectual Property Enforcement Measures: Improving Access to Medicines through WTO Dispute Settlement

Melissa Blue Sky

View PDFchevron_right

Patents and Public Health in the WTO, FTAs and Beyond: Tension and Conflict in International Law

Tania Voon, Andrew D Mitchell

View PDFchevron_right

Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health

Gabriela Chaves

View PDFchevron_right

Global Issues and Business in International Relations: Intellectual Property Rights and Access to Medicines

Yoshiko KOJO

International Relations of the Asia-Pacific, 2018

View PDFchevron_right

Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review

Warren Kaplan

Globalization and Health, 2019

View PDFchevron_right

TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?

Vanessa Kerry

Globalization and Health, 2007

View PDFchevron_right

Lisa Forman, "Human Rights Impact Assessment Of Trade-Related Intellectual Property Rights: A Key Strategy In Post-2015 Efforts To Improve Access To Safe And Accessible Medicines" (2013)

Lisa Forman

(2013) 1:1 Journal of Health Diplomacy

View PDFchevron_right

The Legal Duel: The Trips Agreement and Drug Access Issues

Jae Sundaram

The Denning Law Journal

View PDFchevron_right

Assessing Access to Medicines in Preferential Trade Agreements: From the Trans-Pacific Partnership to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership

Piergiuseppe Pusceddu

International Review of Intellectual Property and Competition Law, 2018

View PDFchevron_right

The High Price of “Free” Trade: U.S. Trade Agreements and Access to Medicines

Ruth Lopert

View PDFchevron_right

Implications of bilateral free trade agreements on access to medicines

Carlos Correa

Bulletin of The World Health Organization, 2006

View PDFchevron_right

TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines

HILDE STEVENS

Pharmaceutics, 2021

View PDFchevron_right

TRIPS PLUS MEASURES UNDER RCEP NEGOTIATIONS THREATEN PUBLIC ACCESS TO MEDICINES (original) (raw)

Related papers